Table 3.
Multinomial analysis of baPWV and carotid plaque number
| baPWV, m/s | One plaque | Two plaques | Three or more plaques | |||
|---|---|---|---|---|---|---|
| aOR (95% CI) | P value | aOR (95% CI) | P value | aOR (95% CI) | P value | |
| Continuous | 1.04 (1.02, 1.06) | <0.001 | 1.04 (1.02, 1.06) | <0.001 | 1.09 (1.07, 1.12) | <0.001 |
| Quartiles | ||||||
| Q1 (<14.81) | Ref. | Ref. | Ref. | |||
| Q2 (14.81 ≤ 16.73) | 1.03 (0.89, 1.18) | 0.708 | 1.07 (0.88, 1.30) | 0.496 | 1.19 (0.96, 1.46) | 0.111 |
| Q3 (16.73 ≤ 19.06) | 1.15 (0.99, 1.33) | 0.072 | 1.47 (1.22, 1.79) | <0.001 | 1.67 (1.36, 2.06) | <0.001 |
| Q4 (≥19.06) | 1.27 (1.08, 1.50) | 0.005 | 1.45 (1.17, 1.79) | <0.001 | 2.20 (1.77, 2.74) | <0.001 |
| P for trend | 0.002 | <0.001 | <0.001 | |||
Adjusted for age, gender, BMI, alcohol consumption status, smoking status, SBP and DBP at baseline, TC, HDL-c; FPG, eGFR, homocysteine, folate, TG, glucose-lowering medication, antihypertensive medication, study center, and folic treatment group
aOR adjusted odds ratio, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, HDL-c high-density lipoprotein cholesterol, FPG fasting plasma glucose, eGFR estimated glomerular filtration rate, TG triglyceride